Page 104 - 72_03

JESÚS PINTOR AN. R. ACAD. NAC. FARM.

(41) CROSSON, C. E. (1995): Adenosine receptor activation modulates intraocular
(42) pressure in rabbits. J. Pharmacol. Exp. Ther. 273: 320-326.
(43) CROSSON, C. E. and GRAY, T. (1996): Characterization of ocular hipertensión
(44) induced by adenosine agonists. Invest. Ophthalmol. Vis. Sci. 37: 1833-1839.
PINTOR, J. and PERAL, A. (2001): Therapeutic potential of nucleotides in the
(45) eye. Drug Dev. Res. 52: 190-195.
SOTO, D.; PINTOR, J.; PERAL, A., GUAL, A. and GASULL, X. (2005): Effects of
(46) dinucleoside polyphosphates on trabecular meshwork cells and aqueous
humor outflow facility. J. Pharmacol. Exp. Ther. 314: 1042-1051.
(47) PINTOR, J.; SÁNCHEZ-NOGUEIRO, J.; IRAZU, M.; MEDIERO, A.; PELÁEZ, T. and PERAL,
A. (2004b): Immunolocalisation of P2Y receptors in the rat eye. Purinergic
(48) Signalling 1: 83-90.
CUI, M.; SRINIVAS, S. P.; MUTHARASAN, R.; SUN, X. C.; BONANNO, J. A. and YUE,
B. Y. J. T. (2001): Mechanotransduction in cultured trabecular meshwork
(TM) cells (Abstract). Investig. Ophthalmol. Vis. Sci. 42: S140.
CROSSON, C. E.; YATES, P. W.; BHAT, A. N.; MUKHIN, Y. V. and HUSAIN, S. (2004):
Evidence form multiple P2Y receptors in trabecular meshwork cells. J.
Pharmacol. Exp. Ther. 309: 484-489.
SCHACHTER, J. B., LI, Q.; BOYER, J. L.; NICHOLAS, R. A. and HARDEN, T. K. (1996):
Second Messenger cascade specificity and pharmacological selectivity of the
human P2Y1-purinoceptor. Br. J. Pharmacol. 118: 167-173.

538